BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32683470)

  • 1. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.
    Wenter V; Albert NL; Unterrainer M; Ahmaddy F; Ilhan H; Jellinek A; Knösel T; Bartenstein P; Spitzweg C; Lehner S; Todica A
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):449-460. PubMed ID: 32683470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hürthle cell carcinoma.
    Ernaga Lorea A; Migueliz Bermejo I; Anda Apiñániz E; Pineda Arribas J; Toni García M; Martínez de Esteban JP; Insausti Serrano AM
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):136-142. PubMed ID: 29433918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of rare oncocytic papillary (Hürthle cell) thyroid carcinoma following (adjuvant) initial radioiodine therapy.
    Wenter V; Jellinek A; Unterrainer M; Ahmaddy F; Lehner S; Albert NL; Bartenstein P; Knösel T; Spitzweg C; Ilhan H; Todica A
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2526-2535. PubMed ID: 31410542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data.
    Kim WG; Kim TY; Kim TH; Jang HW; Jo YS; Park YJ; Kim SW; Kim WB; Shong M; Park DJ; Chung JH; Shong YK; Cho BY
    Korean J Intern Med; 2014 May; 29(3):325-33. PubMed ID: 24851067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent Hurthle cell thyroid carcinoma does not preclude long-term survival: a case report and review of the literature.
    Blossey RD; Kleine-Döpke D; Ringe KI; Pöhnert D; Ringe B; Klempnauer J; Beetz O
    J Med Case Rep; 2021 Aug; 15(1):399. PubMed ID: 34376229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
    Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
    Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
    Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large (>4 cm) Intrathyroidal Encapsulated Well-Differentiated Follicular Cell-Derived Carcinoma Without Vascular Invasion May Have Negligible Risk of Recurrence Even When Treated with Lobectomy Alone.
    Ghossein R; Ganly I; Tuttle RM; Xu B
    Thyroid; 2023 May; 33(5):586-592. PubMed ID: 36884299
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
    Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
    Thyroid; 2012 Aug; 22(8):798-804. PubMed ID: 22853727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?
    Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
    Ann Surg Oncol; 2013 Sep; 20(9):2944-50. PubMed ID: 23616135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
    Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
    Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes.
    Matsuura D; Yuan A; Wang L; Ranganath R; Adilbay D; Harries V; Patel S; Tuttle M; Xu B; Ghossein R; Ganly I
    Thyroid; 2022 Mar; 32(3):245-254. PubMed ID: 35078345
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hürthle cell carcinoma: A malignancy of low-grade potential.
    Khafif A; Khafif RA; Attie JN
    Head Neck; 1999 Sep; 21(6):506-11. PubMed ID: 10449665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of follicular thyroid carcinoma.
    Ríos A; Rodríguez JM; Ferri B; Martínez-Barba E; Torregrosa NM; Parrilla P
    Endocrinol Nutr; 2015 Jan; 62(1):11-8. PubMed ID: 25156926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.